47 results about "Octadecatrienoic acid" patented technology

This invention relates to a new conjugated linoleic acids, a process for preparation thereof and method of use. Thus this invention is concerned with the preparation and purification of conjugated linoleic acids from materials rich in alpha or gamma linoleic acids. The reaction produces a mixture containing a 1:1 ratio of 9Z, 11E, 15Z-octadecatrienoic acid and 9Z, 13E, 15Z-octadecatrieonic acid. The mixture can be purified up to 90% by liquid chromatography, crystallization or urea crystallization. The mixture of 1:1 9Z, 11E, 15Z-octadecatrienoic acid and 9Z, 13E, 15E, 15Z-octadecatrienoic acid have anticancerous activities.

A medicine for treating various diseases such as women's climacteric syndrome, osteoporosis, mental depression, premature ovarian failure, premenstrual tension syndrome, hyperthyroidism, male and female infertility, hair loss and white hair, and is characterized in that it It is composed of fatty acids in the following weight percent range: hexadecanoic acid 8-32%, hexadecenoic acid 11-35%, octadecenoic acid 13-33%, octadecanoic acid 0.3-2.5%, octadecanoic acid Carbadienoic acid 11-33%, octadecatrienoic acid 3-15%. Compared with other drugs, the drug composition is simple, belongs to the target organ agonist, and has an independent reversible regulation function on the second messenger of the body. It is a medicine with high curative effect, safety and simplification.

The invention relates to a health product, which is characterized in that: the health product comprises timnodonic acid, docosahexaenoic acid, hexadecenoic acid, octadecenoic acid, octadecadienoic acid, octadecatrienoic acid, eicosatetraenoic acid and docosapentaenoic acid, wherein the mass summation of the timnodonic acid and the docosahexaenoic acid accounts for 35 to 40 percent of the total mass, and the mass summation of the hexadecenoic acid, the octadecenoic acid, the octadecadienoic acid, the octadecatrienoic acid, the eicosatetraenoic acid and the docosapentaenoic acid accounts for 60 to 75 percent of the total mass. The contents of fish oil extracts EPA and DHA prepared by the method are between 35 and 40 percent; and the deep sea fish oil prepared from the extracts taken as main raw materials has the advantages of having an obvious lipid-reducing effect, diversifying active ingredients, and achieving the effects of inhibiting platelet aggregation, lowering neutral lipid in blood, lowering cholesterol of low density lipoprotein and low density lipoprotein, increasing high density cholesterol, lowering blood viscosity, lowering cholesterol, preventing heart cerebrovascular diseases, reducing arterial pressure, alleviating gout and rheumatoid arthritis, improving the development of the brain and eyes and the like, so that the health product is the best choice of middle and old-aged people.

A health-care mixed plant oil containing linolenic acid for decreasing blood fat and blood viscosity contains gamma-linolenic acid (0.4-1.8 wt.%), alpha-linolenic acid (40-85 wt.%) and beta-linolenic acid (0.28-1.5 wt.%). It can be directly eaten or made into capsule or tables. Its advantages are quickly taking its effect and low cost.

An inductive production-increase agent for the honeybee pollination on flowering plants comprises (E)-9-Oxodec-2-enoic acid (9-ODA), R (-)-9-hydroxy-(E)-2-decenoic acid (R(-)-9HDA), S(+)-9-hydroxy-(E)-2-decenoic acid (S (+) -9HDA), Methyl 4-hydroxybenzoate (HOB), 4-hydroxy-3-methoxyphenylacetic (HVA), 9-Octadecenoic acid methyl ester (methyl oleate), (E)-4-(4-Hydroxy-3-methoxypheny)-3-2-propen-1-ol (coniferyl alcohol), hexadecanol and (Z9, Z12, Z15)-9, 12, 15-octadecatrienoic acid (linolenic acid); the invention can effectively induce a honeybee to pollinate on flowering plants. The inductive production-increase agent has a positive effect on the production increase of honeybee pollination on blueberries and cherries; it effectively extrudes the application of the queen bee flowing element in the inductive production increase in the pollination on blueberries and cherries.

Here the inventors provide a composition for topical application to the skin of animal comprising stearidonic acid in combination with one or octadecatrienoic acids (CODTAs). Preferably the composition comprises echium oil as a source of the stearidonic acid, and a plant lipid as a source of octadecatrienoic acid, such as borage oil (Borago officinalis), wheat germ oil (Triticum vulgare) rosehip oil (refined; Rosa mosqueta), jacaranda oil (Jacandra mimosi folia), and / or calendula oil (Calendula officinalis). The composition of the invention increases collagen I secretion and thus has particular utility for promoting collagen production in skin.

The present invention relates to a combination of a hermetically sealed, substantially air-tight container and a nutritional composition. The container of the present invention is adapted for the convenient transport, and storage of a single daily oral dose of a nutritional composition containing a fatty acid, for example, diacyl glycerol, an octadecatrienoic acid, an octadecadienoic acid, linolenic acid, linoleic acid, conjugated linoleic acid (CLA) or a combination thereof. In a preferred embodiment, the present invention relates to the use of the c9, t11 and t10, c12 isomers of CLA in a nutritional composition. The wide range of health benefits associated with consumption of these CLA fatty acids is well known. Furthermore, the invention relates to a container that substantially prevents CLA lipid oxidation caused by exposure to air.

The invention relates to blend oil containing 48% of linoleic acid and 12% of linolenic acid in a ratio of 4:1, which mainly takes selected perilla oil, bean oil and olive oil as raw materials and has the main advantages of solving the problems of low content of omega-3 (linolenic acid) and proportional imbalance of linoleic acid and linolenic acid and remedying the shortage that the omega-3 (linolenic acid) is generally lacked in a human body, wherein the omega-3 (linolenic acid) is octatecatrienoic acid which can be used for preventing the platelet aggregation and reducing the generation of thrombotic diseases; the generated EPA (EicosaPentaenoic Acid) which is called dustman of blood vessel by medical experts has the effects of lowering the blood lipid, lowering the blood viscosity, improving the blood circulation and softening the blood vessel; and the generated DHA (DocosaHexaenoic Acid) which is called plant brain gold by nutritionists has the effects of replenishing the brain nutrition, preventing the senile dementia and improving the vision. By means of the blend oil, the epidemics of three high and four diseases and the generation of various chronic diseases such as cancers and the like are controlled from the source of foodstuffs.

An application of refined fur seal oil "OMEGA 3" in preparing the medicines for preventing and treating senile dementia and apoplexy sequela is disclosed. Said defined fur seal oil "OMEGA 3" containsoctadecadienoic acid, octadecatrienoic acid, EPA, DPA, DHA, squalene, VE, unsaturated fatty acid, and saturated fatty acid.

The invention relates to the iatrochemistry field, in particular to a method for treating burn and scald, sunburn, bedsore, ulceration, frostbite and wound. Octadecadienoic calcium is not applied in the disease therapy field at present. In the invention the octadecadienoic calcium is made into ointment or oil-type spraying agent for external use; the octadecadienoic calcium is got by eleostearic acid reacting with sodium bicarbonate and then in liquid-liquid reaction with calcium hydroxide water, or by eleostearic acid glyceride reacting with calcium hydroxide. The invention brings evident effect to burn and scald, sunburn, bedsore, ulceration, frostbite and wound, cut fail to heal and the postoperative long-term ulceration caused by anal fissure, anal fistula or genital inflammations, also to dermatophytosis, mosquito bites and inflamed acne. Low production cost, no side effects, security and reliability make the invention easy to be promoted.

The present invention relates to a kind of medicinal composition for preventing and treating female senile diseases and its preparation process. The medicinal composition consists of isoflavone, panoxadiol type saponin, cimicifuga rhizome extract and calendic acid. It has high stability, and can replenish female with paraestrogen to prevent diseases caused by estrogen decrease, improve senility symptoms, nurse skin, resist oxidation and eliminate the accumulation of free radical and other toxic matters.